Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3) , 29-34
- https://doi.org/10.1016/0732-8893(89)90062-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Long-term oral ciprofloxacin: Experience in the treatment of incurable infective endocarditisThe American Journal of Medicine, 1988
- Development of Resistance in Pseudomonas aeruginosa to Imipenem, Norfloxacin, and Ciprofloxacin During Therapy: Proof Provided by Typing with a DNA ProbeThe Journal of Infectious Diseases, 1988
- In vitro and in vivo activity of NY-198, a new difluorinated quinoloneAntimicrobial Agents and Chemotherapy, 1987
- Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacinAntimicrobial Agents and Chemotherapy, 1986
- Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactionsAntimicrobial Agents and Chemotherapy, 1985
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- The estimation of the bactericidal power of the bloodEpidemiology and Infection, 1938